Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Pharmacology & Therapeutics|August 23, 2005
GPCR modulation by RAMPsDebbie L Hay, David R Poyner, Patrick M Sexton
Pharmacology & Therapeutics|April 11, 2025
Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeuticsZoe Tasma, Michael L Garelja, Aqfan Jamaluddin, et al.
Biophysical Journal|April 25, 2006
Characterization of the structure of RAMP1 by mutagenesis and molecular modelingJohn Simms, Debbie L Hay, Mark Wheatley, et al.
British Journal of Pharmacology|June 11, 2011
The pharmacology of adrenomedullin 2/intermedinYanguo Hong, Debbie L Hay, Remi Quirion, et al.
Frontiers in Pharmacology|September 25, 2020
Antagonism of CGRP Signaling by Rimegepant at Two ReceptorsKylie S Pan, Andrew Siow, Debbie L Hay, et al.
Peptides|March 30, 2010
A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptorJoseph J Gingell, Tao Qi, Richard J Bailey, et al.
International Journal of Molecular Sciences|December 23, 2022
Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary TaleErica R Hendrikse, Tayla A Rees, Zoe Tasma, et al.
Cephalalgia : an International Journal of Headache|March 24, 2018
Molecular studies of CGRP and the CGRP family of peptides in the central nervous systemErica R Hendrikse, Rebekah L Bower, Debbie L Hay, et al.
Pageof 14